The Efficacy of Integrated Rehabilitation for Post-Stroke Anxiety: Study Protocol for a Prospective, Multicenter, Randomized Controlled Trial
Jie Zhou,Lijuan Fan,Hantong Hu,Ke Shen,Liya Wu,Xiaoqi Lin,Hong Gao
DOI: https://doi.org/10.2147/IJGM.S381434
IF: 2.145
2022-09-06
International Journal of General Medicine
Abstract:Jie Zhou, 1, &ast Lijuan Fan, 2, &ast Hantong Hu, 1 Ke Shen, 2 Liya Wu, 2 Xiaoqi Lin, 2 Hong Gao 1 1 Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China; 2 The Third Clinical College of Zhejiang Chinese Medical University, Hangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hong Gao, Department of Acupuncture and Moxibustion, The Third Affiliated Hospital of Zhejiang Chinese Medical University, No. 219 Moganshan Road, Hangzhou, People's Republic of China, Email Background: Post-stroke anxiety (PSA) remains a challenging medical problem. Integrated rehabilitation involves a combination of traditional Chinese medicine (TCM) and Western conventional rehabilitation techniques. Theoretically, integrated rehabilitation is likely to have significant advantages in treating PSA. Nevertheless, the therapeutic effect of integrated rehabilitation needs to be verified based on large-scale trials with sound methodology. Thus, the aim of this trial is to assess the efficacy and safety of integrated rehabilitation on PSA. Methods: The study is a prospective, multicenter, randomized, controlled trial involving 188 PSA patients from four clinical centers in China. Eligible participants will be randomly divided into the integrated rehabilitation group or the standard care group. Participants in the integrated rehabilitation group will receive a combination of TCM and Western conventional rehabilitation methods, including acupuncture, repeated transcranial magnetic stimulation, traditional Chinese herbal medicine, and standard care. The primary outcome will be the Hamilton Anxiety Rating Scale (HAM-A). The secondary outcomes will include the Self-Rating Anxiety Scale (SAS), the Activities of Daily Living (ADL) scale, the Montreal Cognitive Assessment (MoCA) scale, the simplified Fugl–Meyer Assessment of motor function (FMA) scale, and the Pittsburgh Sleep Quality Index (PSQI). Outcome measurements will be performed at baseline, at the end of the 4-week treatment and the 8-week follow-up. Conclusion: Results of this trial will ascertain the efficacy and safety of integrated rehabilitation on PSA, thereby providing evidence regarding integrated rehabilitation strategies for treating PSA. It will also promote up-to-date evidence for patients, clinicians, and policy-makers. Trial Registration: ClinicalTrials.gov NCT05147077. Keywords: post-stroke anxiety, traditional Chinese medicine, Western medicine, repeated transcranial magnetic stimulation, rehabilitation, randomized controlled trial Stroke is the second leading cause of death globally. 1 The estimated global lifetime risk data show that the lifetime risk of stroke for people aged above 25 years was 24.9%. 2 China has the highest estimated lifetime risk of stroke (39.3%) in the world according to global, regional, and country-specific lifetime risk of stroke and the 2017 Global Burden of Disease Study. 3 And stroke has been the leading cause of death and disability in China in recent years. 4 Post-stroke anxiety (PSA) is a common psychological complication of stroke, impacting the quality of life and functional decline. The estimated global prevalence of PSA ranges from 18% to 25%, 5 while in a Jordanian survey, the figure is up to 52.9%. 6 PSA aggravates cognitive dysfunction, delays the recovery process, and increases the disability, mortality, and recurrence rates of stroke. Therefore, it is vital to perform early clinical interventions for PSA to improve the prognosis and restore the social function of stroke patients. To date, there have been no specific and uniform guidelines for the treatment of PSA. For the treatment of PSA, current treatments mainly include pharmacological therapies, psychotherapy, and rehabilitation. In addition, some patients also seek complementary and alternative therapies. 7,8 As it is widely believed that anxiety is associated with increased disability and decreased quality of life, 9 improving movement function is fundamental for PSA. Thus, rehabilitation therapy is an important treatment approach for PAS. However, it is worth noting that the majority of previous studies focus on the efficacy of specific rehabilitation therapy, but ignore the important concept of "integrated rehabilitation", thereby failing to achieve optimal efficacy. Thus, it is of significance to develop an integrated rehabilitation scheme for PSA. The concept of "integrated rehabilitation" in our study is derived from "integrative m -Abstract Truncated-
medicine, general & internal